Our findings reveal that axitinib could induce senescence in human lung adenocarcinoma cells and that this effect was unrelated to inhibition of VEGFR signaling of cancer cells, indicating an unforeknown effect of axitinib on cancer cells. Here, KDR is linked to cancer.